Matthew Robson
Research Fellow
Last active: 10/19/2015

  1. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR (2013) Exp Neurol : 134-42
    › Primary publication · 23631864 (PubMed) · PMC3742718 (PubMed Central)
  2. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. Kaushal N, Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR (2013) Eur Neuropsychopharmacol 23(8): 960-71
    › Primary publication · 22921523 (PubMed) · PMC3748261 (PubMed Central)
  3. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ, Gettens RT, Matsumoto RR, Huber JD, Rosen CL (2013) Exp Neurol : 520-9
    › Primary publication · 23876514 (PubMed)
  4. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine. Seminerio MJ, Robson MJ, Abdelazeem AH, Mesangeau C, Jamalapuram S, Avery BA, McCurdy CR, Matsumoto RR (2012) AAPS J 14(1): 43-51
    › Primary publication · 22183188 (PubMed) · PMC3291180 (PubMed Central)
  5. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus. Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR (2012) Eur J Pharmacol 691(1-3): 103-9
    › Primary publication · 22820108 (PubMed) · PMC3726051 (PubMed Central)
  6. Sigma-1 receptors: potential targets for the treatment of substance abuse. Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR (2012) Curr Pharm Des 18(7): 902-19
    › Primary publication · 22288407 (PubMed)
  7. Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? Turner RC, Lucke-Wold BP, Robson MJ, Omalu BI, Petraglia AL, Bailes JE (2012) Front Neurol : 186
    › Primary publication · 23335911 (PubMed) · PMC3547169 (PubMed Central)
  8. Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. Robson MJ, Elliott M, Seminerio MJ, Matsumoto RR (2012) Eur Neuropsychopharmacol 22(4): 308-17
    › Primary publication · 21911285 (PubMed)
  9. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Xu YT, Robson MJ, Szeszel-Fedorowicz W, Patel D, Rooney R, McCurdy CR, Matsumoto RR (2012) Pharmacol Biochem Behav 101(1): 174-80
    › Primary publication · 22234290 (PubMed) · PMC3726055 (PubMed Central)
  10. AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Kaushal N, Elliott M, Robson MJ, Iyer AK, Rojanasakul Y, Coop A, Matsumoto RR (2012) Mol Pharmacol 81(3): 299-308
    › Primary publication · 22101517 (PubMed) · PMC3286303 (PubMed Central)